Multiplex Molecular Diagnostics Market

Multiplex Molecular Diagnostics Market: Outlook

The multiplex molecular diagnostics market may observe a paradigm shift in the growth rate across the forecast period of 2020-2030 due to the growing threat of the novel coronavirus pandemic. The need for effective testing to contain the spread of COVID-19 is on top priority across the globe. Various researchers, scientists, and pharma companies are coming up with novel testing methods for rapid diagnosis. The multiplex molecular diagnostics system is one of them. Therefore, the multiplex molecular diagnostics market may bring extensive growth opportunities during the forecast period.

Multiplex tests provide a speedy diagnosis as compared to other methods. Hence, this factor may enhance the growth rate of the multiplex molecular diagnostics market greatly. In addition, an increase in the prevalence of respiratory and gastrointestinal disorders may serve as a prominent growth contributor for the multiplex molecular diagnostics market. Based on method, the global multiplex molecular diagnostics market can be classified into Real-time PCR, PCR with Electrochemical Detection, PCR with Liquid Phase Bead Array, Nested PCR with Melt Curve Analysis, PCR with Electrochemical Detection, and PCR with Low density Microarray.

This upcoming report on the multiplex molecular diagnostics market provides an in-depth analysis of the current market situation. The report covers components like competitive landscape, key players, regional analysis, and ongoing trends. The report also offers thorough research on how the COVID-19 pandemic will impact the multiplex molecular diagnostics market. The segmental study enables an individual to thoroughly understand the different aspects of the multiplex molecular diagnostics market systematically.

Multiplex Molecular Diagnostics Market: Competitive Dynamics

The novel coronavirus pandemic has brought immense loss to the humankind across the globe. To tackle the growing transmission of COVID-19, rapid testing measures are necessary. The growing influence of RT-PCR testing kits as the gold standard of testing has invoked tremendous demand from various countries. This aspect may prompt the multiplex molecular diagnostics market manufacturers to increase their production capacity.

Many new players are also entering in the multiplex molecular diagnostics market to meet the demand of diagnostic kits around the world. This development may further elevate the competition across the multiplex molecular diagnostics market. Speedy authorizations by regulatory bodies like the FDA are also proving to be of great help for increasing the growth rate of the multiplex molecular diagnostics market.

Multiplex Molecular Diagnostics Market: Important Partnerships

• Sherlock biosciences and Binx Health recently announced a partnership for developing the world’s first rapid point-of-care diagnostic test for COVID-19 based on CRISPR technology
• SpeeDx and Roche have partnered to expand access to antibiotic resistance tests
• Contextual Genomics and Lab Genomics recently declared a partnership to provide cutting-edge liquid biopsy cancer testing

Multiplex Molecular Diagnostics Market: Key Trends

The novel coronavirus pandemic has resulted in enhanced research and development activities for creating cost-effective and precise testing kits. For instance, the Indian Institute of Technology (IIT), Delhi recently created Corosure, a low-cost RT-PCR testing kit with the base price of ?399 (~US$ 5). The development of such affordable RT-PCR testing kits may bring an increase in demand for the testing kits greatly.

Novel technological developments are also bringing considerable momentum for increasing the growth rate of the multiplex molecular diagnostics market. For instance, Bosch Healthcare Solutions developed one of the world’s first multiplex molecular diagnostics tests for the Vivalytic platform that can perform the dual function of COVID-19 detection as well as distinguish it from more than 8 respiratory infections. This product can help in the differentiation of patients and will eliminate unnecessary confusion. 

Multiplex Molecular Diagnostics Market: Regional Landscape

The multiplex molecular diagnostics market can be geographically segmented into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific. With the U.S. being the worst-hit country by the novel coronavirus, rapid testing is the need of the hour to contain the transmission. Therefore, North America may bring good growth for the multiplex molecular diagnostics market. The rising cases of COVID-19 in densely populated countries like India may enable Asia Pacific to bring substantial growth for the multiplex molecular diagnostics market.